Mirion Releases InstadoseVUE Wireless Dosimeter
Mirion Dosimetry Services launched the InstadoseVUE wireless dosimeter designed to monitor individual radiation exposure.
Mirion Dosimetry Services launched the InstadoseVUE wireless dosimeter designed to monitor individual radiation exposure.
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corp., announces the release of the MobileDaRt Evolution MX8 Version V type. The product is currently being displayed at the AHRA Annual Meeting and Exposition.
Lexington, Mass.-based Fujifilm Medical Systems U.S.A. Inc. announces that it has been awarded a 10-year sole source contract for its digital radiography systems from the U.S. Navy and Defense Logistics Agency.
Mirion Dosimetry Services launched the InstadoseVUE wireless dosimeter designed to monitor individual radiation exposure.
Arcoma launched the Omnera 500A X-ray system through company partner Canon Medical Systems USA at the RSNA annual meeting.
Read MoreNanox will provide information on its digital x-ray source and a live demo of the Nanox.ARC in a range of 2D and 3D medical imaging procedures.
Read MoreTeleradiologia de Colombia is rolling out Oxipit AI solutions across its network. It marks the first Oxipit deployment in Colombia.
Read MoreNanox has raised an additional $59 million in funding for full-body scanning hardware designed to replace X-rays and change medical imaging infrastructure.
Read MoreThe Medical Device Innovation Consortium (MDIC), announced that CVRx’s President and CEO Nadim Yared has been named chairman of the MDIC Board of Directors and Executive Committee for a two-year term.
Read MoreAt the annual meeting of the Radiological Society of North America, which took place last week in Chicago, Wayne, N.J.-based Konica Minolta Healthcare Americas, Inc. showcased upgrades to its AeroRemote platform. With AeroRemote Insights, managers can evaluate system performance by reviewing digital radiography panel impact events, among other activities.
Read MoreSeveral vascular physicians report positive patient outcomes with company's next-generation Pantheris system for the treatment of peripheral artery disease.